There were 2,407 press releases posted in the last 24 hours and 440,364 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
ContraFect Presents Additional Positive Data from the Phase 2 Trial of Exebacase at the 29th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID)

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image